Stevia Corp., an international farm management company focused on the commercial development of natural products that support a healthy lifestyle, including stevia and hemp and their extracts, is pleased to announce that it is preparing to fulfill commercial orders for hemp products following the upcoming Fall harvest.
Real Hemp LLC, Stevia Corp's wholly owned subsidiary, is confirming orders from US manufactures wanting to purchase hemp products and is preparing to fulfill these orders when the current hemp crop is harvested beginning in October 2014. Products range from hemp seeds and their by-products such as edible oil (richest source of essential fatty acids) and protein (contains all of the essential amino acids and is easy to digest) to fiber (used by more than 65 industries) and cannabidiol (CBD) extract (sought for medical applications and used as a dietary supplement).
George Blankenbaker, Stevia Corp President, comments, "It is interesting to note that China, which grows over 70% of the world's hemp, is supplying Canadian companies who are not able to meet the growing demand of their US customers. While hemp is not approved for commercial growing in the US, we will work with our partners in China to meet the growing demand and develop the technologies that will be needed for efficient post harvest processing in the US once production is approved."
Real Hemp is also in the process of setting up a joint venture company in China to apply for an industrial hemp cultivation and processing license. The license includes commercial extraction of CBD and will enable development of further science and technology in this area.
George Blankenbaker adds, "The laws in China, as in many countries, are very strict regarding the growing and transportation of hemp plant material and the extraction of cannabinoids from hemp. However, our local Chinese partner meets the requirements to apply for a cultivation and processing license and the JV company will be able to obtain the license for commercial production of all parts of the hemp plant including the extraction of CBD and other non-psychoactive cannabinoids."
Further details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934, as amended, filed with the Securities and Exchange Commission's EDGAR database.
